TY - JOUR T1 - Reconsidering Repositioning Incentives: An Empirical Legal Analysis of Market Protection for New Therapeutic Indications A1 - Liddicoat, Johnathon A1 - Liddell, Kathleen A1 - Fritz, Zoƫ PY - 2021 N2 - In Europe, drugs that are shown to have new therapeutic indications can receive additional market protection. This study analyses all instances this extra protection was awarded up until the end of 2020. This study pioneers a method to analyse what type of new indications receive the extra protection and shows that it was awarded for treating new patient cohorts as often as new medical conditions. No evidence supports granting extra protection for new patient cohorts. Therefore, this paper argues to pare back the circumstances the extra protection is awarded. JF - European Pharmaceutical Law Review JA - European Pharmaceutical Law Review VL - 5 IS - 3 UR - https://doi.org/10.21552/eplr/2021/3/4 M3 - doi:10.21552/eplr/2021/3/4 ER -